Search for: "Taylor v. General Motors Company" Results 21 - 40 of 47
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
8 Jun 2009, 2:00 am
Second Taylor Wessing Global IP Index reviews 24 places to litigate patents (PatLit) Discussion of ‘IFI Patent Intelligence Analysis of 2008’s Top US-Patent Recipients Suggests America May be Losing Dominance: Companies Outside the U.S. [read post]
8 Jun 2009, 2:00 am
Second Taylor Wessing Global IP Index reviews 24 places to litigate patents (PatLit) Discussion of ‘IFI Patent Intelligence Analysis of 2008’s Top US-Patent Recipients Suggests America May be Losing Dominance: Companies Outside the U.S. [read post]
6 Jul 2007, 4:29 am
Thus, at best, Karl has just created a regime of redundant and overlapping liability with the patients stuck in the middle - not knowing whom to believe if doctors and drug companies say different things.The learned intermediary rule thus makes sound practical sense. [read post]
20 Feb 2019, 2:13 pm by admin
General Court Rules Article 10, § 2 of the 1963 Constitution requires that “compensation shall be determined in proceedings in the court of record. [read post]
13 May 2022, 4:00 am by Jim Sedor
National/Federal A 49-Year Crusade: Inside the movement to overturn Roe v. [read post]
13 Jun 2008, 3:40 am
: (Patent Docs), Generic drug developers will continue to take advantage of global demand for lower-priced drugs, with Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada: Generics to penetrate 26% pharma market in Canada says RNCOS research: (GenericsWeb), Canada: Generic drug makers spreading misinformation about patent regulation… [read post]
1 Oct 2009, 5:48 pm by admin
Court of Appeals for the Second Circuit held in State of Connecticut v. [read post]
9 May 2018, 9:40 am by John Elwood
BNSF Railway Company v. [read post]
19 Nov 2009, 10:51 am by Beck/Herrmann
You've got a court in California, but nobody else, allowing "misrepresentation" liability for a brand-name company in a generic drug case. [read post]